Abstract: A method of patient stratification between respondents and non-respondents to immuno-oncology (IO). This method, based on deep-learned features extracted owing to automatic AI-based models that have been fully-trained, goes beyond traditional radiomic standards, opening new perspective for a broader uptake of machine learning solutions in both patient care and drug development. Based on latest Machine Learning advances, the here proposed method allows predicting non-invasively a patient's tumor response to immuno-oncology therapy based treatment. The here proposed method operates not only on early stage conditions though a whole organ and lesion-agnostic analysis for prediction, but also on advanced metastatic stages through a multi-organ analysis performing a disease-agnostic and stage-agnostic prediction, potentially in accordance with response criteria defined by the RECIST 1.1 evaluation methodology.

Abstract: A method for performing classification of the severity of at least one liver disease from non-invasive radiographic images is disclosed. The method includes: providing radiographic images of slices of the abdomen of a patient; pre-processing the radiographic images by: segmenting liver and spleen, thus achieving a spleen binary mask and a liver binary mask per slice, and normalizing the images with each other, thus achieving normalized radiographic images per slice; for each slice, from the liver binary mask and the normalized radiographic images, extracting a liver parameter; from at least one spleen binary mask, extracting a spleen parameter; and classifying, in function of both parameters and by help of a trained Machine Learning model, the severity of liver disease between one among a group of liver disease at early stage and a group of liver disease at advanced stage.